BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18597631)

  • 1. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
    Plotkin LI; Lezcano V; Thostenson J; Weinstein RS; Manolagas SC; Bellido T
    J Bone Miner Res; 2008 Nov; 23(11):1712-21. PubMed ID: 18597631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
    Bellido T; Plotkin LI
    Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
    Plotkin LI; Bivi N; Bellido T
    Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
    Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
    J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.
    Lezcano V; Bellido T; Plotkin LI; Boland R; Morelli S
    Arch Biochem Biophys; 2012 Feb; 518(2):95-102. PubMed ID: 22230328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
    Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
    J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
    Plotkin LI; Manolagas SC; Bellido T
    Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice.
    Watkins MP; Norris JY; Grimston SK; Zhang X; Phipps RJ; Ebetino FH; Civitelli R
    Bone; 2012 Oct; 51(4):787-94. PubMed ID: 22750450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice.
    Tsuboi K; Hasegawa T; Yamamoto T; Sasaki M; Hongo H; de Freitas PH; Shimizu T; Takahata M; Oda K; Michigami T; Li M; Kitagawa Y; Amizuka N
    Histochem Cell Biol; 2016 Sep; 146(3):337-50. PubMed ID: 27235014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate.
    Lezcano V; Bellido T; Plotkin LI; Boland R; Morelli S
    Exp Cell Res; 2014 May; 324(1):30-9. PubMed ID: 24698731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice.
    Davis HM; Aref MW; Aguilar-Perez A; Pacheco-Costa R; Allen K; Valdez S; Herrera C; Atkinson EG; Mohammad A; Lopez D; Harris MA; Harris SE; Allen M; Bellido T; Plotkin LI
    JBMR Plus; 2018 Jul; 2(4):206-216. PubMed ID: 29978155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
    Weinstein RS; Jilka RL; Parfitt AM; Manolagas SC
    J Clin Invest; 1998 Jul; 102(2):274-82. PubMed ID: 9664068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice.
    Pacheco-Costa R; Davis HM; Atkinson EG; Katchburian E; Plotkin LI; Reginato RD
    J Musculoskelet Neuronal Interact; 2016 Mar; 16(1):45-57. PubMed ID: 26944823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
    Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
    J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
    Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
    Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone.
    Bivi N; Nelson MT; Faillace ME; Li J; Miller LM; Plotkin LI
    Calcif Tissue Int; 2012 Sep; 91(3):215-24. PubMed ID: 22865265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.
    Zhou JZ; Riquelme MA; Gu S; Kar R; Gao X; Sun L; Jiang JX
    Oncogene; 2016 Oct; 35(43):5597-5607. PubMed ID: 27041582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice.
    Sato AY; Tu X; McAndrews KA; Plotkin LI; Bellido T
    Bone; 2015 Apr; 73():60-8. PubMed ID: 25532480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.